Portfolio Rapha Capital Management

AsclepiX Therapeutics Selected to Present at Ophthalmology Innovation Summit (OIS) at the American Society for Retinal Surgeons (ASRS) Annual Conference

By Kevin SlawinApril 29, 2019February 4th, 2021No Comments

NexImmune, Inc.
Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials
Partnership yields the first investment from newly launched MMRF Myeloma Investment Fund
April 29, 2019

Previous PostPoseida Therapeutics Receives US FDA Orphan Drug Designation for P-BCMA-101 for the Treatment of Multiple Myeloma
Next PostRapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals

© 2024 Ponce Therapeutics. Privacy Policy | Terms & Conditions